11/11 Lecture
Pathology of Glycogen Metabolism
Pathological consequences of defective glycogen metabolism:
Inborn errors and diseases arise from the genetic inability to properly synthesize or degrade glycogen.
These metabolic disorders stem from loss-of-function mutations in essential enzymes governing glycogen synthesis, branching, debranching, and breakdown.
Primary organ systems and tissues affected:
Liver tissue: The liver serves as the central metabolic hub for maintaining systemic blood glucose homeostasis through glycogen synthesis (glycogenesis) and breakdown (glycogenolysis).
Muscle tissue: Skeletal muscle maintains extensive glycogen stores dedicated to generating intracellular energy to fuel muscle contraction.
Due to the concentrated reliance of liver and muscle on glycogen turnover, clinical manifestations of glycogen storage diseases localize predominantly to these two tissues.
Enzymes implicated in glycogen storage pathologies:
Glycogen synthase
Branching enzyme
Debranching enzyme
Glycogen phosphorylase
Clinical presentation in pediatric development:
Newborn infants with mutations in these enzymes exhibit impaired physical growth.
Affected infants consistently fail to reach standard developmental milestones at expected normal rates.
Principles of Reciprocal Regulation in Glycogen Metabolism
Necessity of reciprocal regulation:
Cells must coordinate metabolic flux so that glycogen synthesis is activated while glycogen degradation is simultaneously inhibited, and vice versa.
Simultaneous, uncontrolled activity of both opposing pathways would cause futile energy consumption without net physiological work.
Targeted regulatory control points:
Glycogen metabolism is carried out by a small number of dedicated enzymes.
Shared bidirectional enzymes, such as phosphoglucomutase (which reversibly converts glucose 1-phosphate to glucose 6-phosphate in both directions), are not utilized as regulatory control points.
Regulation is concentrated exclusively on the two unidirectional, rate-limiting enzymes of glycogen turnover:
Glycogen phosphorylase: The primary enzyme responsible for catalyzing the phosphorolytic cleavage and removal of individual glucose residues from glycogen chains.
Glycogen synthase: The primary enzyme responsible for catalyzing the addition of glucosyl residues to elongate glycogen chains.
The and nomenclature system:
Glycogen phosphorylase was one of the earliest enzymes purified and biochemically characterized, establishing an alphabetic naming convention that was subsequently extended to glycogen synthase:
form: Denotes the catalytically active state of the enzyme.
form: Denotes the catalytically inactive (or less active) state of the enzyme.
Enzyme interconversion between the inactive state and the active state is governed reversibly by covalent phosphorylation and dephosphorylation.
Upstream regulatory inputs:
Hormonal signaling cascades, including insulin, glucagon, and epinephrine, control the directional shift between the and states to coordinate systemic carbohydrate metabolism.
Regulation of Glycogen Phosphorylase
Functional objective during insulin signaling:
High circulating blood glucose stimulates insulin secretion to promote glucose uptake, clearance, and storage.
To direct glucose into glycogen storage, glycogen phosphorylase must be kept in its inactive conformation to prevent premature breakdown.
Covalent modification mechanism:
Interconversion between the and forms is driven by reversible phosphorylation at a specific serine residue on the enzyme.
Phosphorylated serine: Converts the enzyme into the active conformation, termed glycogen phosphorylase .
Dephosphorylated serine: Converts the enzyme into the inactive conformation, termed glycogen phosphorylase .
Enzymes controlling the phosphorylation state of glycogen phosphorylase:
Protein Phosphatase 1 (PP1):
Historically designated as phosphorylase phosphatase due to its direct dephosphorylation of glycogen phosphorylase.
Removes the phosphate group from the serine residue of glycogen phosphorylase , converting it into the inactive form.
PP1 is the identical phosphatase that regulates reciprocal control in glycolysis and gluconeogenesis, providing unified enzymatic control across all carbohydrate pathways.
Phosphorylase kinase:
The dedicated kinase that transfers a phosphate group onto the serine residue of glycogen phosphorylase , converting it into the active form.
Physiological activation conditions:
Glycogen phosphorylase is activated when the body requires rapid energy mobilization and increased blood sugar.
Glucagon signaling: Secreted during fasting or starvation states, targeting hepatic receptors to stimulate glycogen mobilization.
Epinephrine signaling: Released during acute stress (fight-or-flight response), targeting both hepatic and skeletal muscle receptors to trigger immediate fuel breakdown.
Receptor binding and cascade amplification:
Both glucagon and epinephrine bind to cell surface G-protein coupled receptors (GPCRs / G protein cell receptors).
Hormone binding induces an allosteric conformational change in the GPCR, activating intracellular signaling.
Signal amplification occurs through second-messenger intermediates: a single activated Protein Kinase A (PKA) enzyme activates multiple phosphorylase kinase enzymes.
Each activated phosphorylase kinase enzyme subsequently phosphorylates and activates multiple glycogen phosphorylase molecules, enabling rapid, high-capacity phosphorolysis of glycogen.
Glucose Sensing Mechanism of Glycogen Phosphorylase
Autonomous glucose-sensing function:
Glycogen phosphorylase possesses an intrinsic sensory capacity that allows elevated intracellular glucose to directly facilitate the shutoff of its own catalytic activity.
Mechanism in hepatic cells:
During active glycogenolysis, liver cells generate free glucose and export it across the plasma membrane into the bloodstream via facilitated transport down a concentration gradient.
When blood glucose concentrations rise (such as following dietary carbohydrate intake), the trans-membrane concentration gradient diminishes.
Because the concentration gradient flattens, facilitated export of glucose from the liver cell slows, causing intracellular free glucose levels to accumulate.
Allosteric conformational response to glucose binding:
Accumulated intracellular glucose binds to an allosteric inhibitory site on glycogen phosphorylase .
Glucose binding triggers a conformational shift that causes the phosphorylated serine residues to swing outward from the interior of the protein.
This conformational change exposes the attached phosphate groups directly to the aqueous solvent.
The exposed phosphate groups become accessible substrates for Protein Phosphatase 1 (PP1).
PP1 rapidly hydrolyzes and removes the exposed phosphates, converting glycogen phosphorylase to the inactive form and terminating glycogen degradation.
Regulation of Glycogen Synthase
Nomenclature and activity states:
Glycogen synthase conforms to the and nomenclature:
Glycogen synthase : The unphosphorylated, catalytically active conformation.
Glycogen synthase : The phosphorylated, catalytically inactive conformation.
Inverted logic of covalent phosphorylation:
Unlike glycogen phosphorylase, phosphorylation inhibits glycogen synthase activity.
The unphosphorylated state is catalytically active; the phosphorylated state is catalytically inactive.
This inverse relationship ensures reciprocal control: adding phosphate groups simultaneously turns on glycogen breakdown (activating phosphorylase) and turns off glycogen synthesis (inactivating synthase). Removing phosphate groups achieves the exact opposite.
Activation pathways:
Insulin signaling stimulates Protein Phosphatase 1 (PP1).
Active PP1 removes the inhibitory phosphate groups from glycogen synthase , shifting it to the active form to drive glycogenesis.
Allosteric activation: Glucose 6-phosphate acts as a positive allosteric regulator. Elevated intracellular glucose 6-phosphate binds to glycogen synthase, stimulating its activity to accelerate the conversion of excess carbohydrate into glycogen.
Inactivation pathways and kinase cooperative mechanism:
Glucagon and epinephrine signaling promote the inactivation of glycogen synthase to prevent futile synthesis during energy mobilization.
Two distinct kinases operate in sequence to transition glycogen synthase from the active form to the inactive form:
Casein kinase 2 (CK2):
Acts as a priming kinase by adding an initial set of phosphate groups onto glycogen synthase.
Phosphorylation by CK2 does not directly suppress enzymatic activity; instead, it pre-conditions and primes the enzyme structure to generate a binding recognition site for the downstream regulatory kinase.
Glycogen synthase kinase 3 (GSK3 / GST3):
The primary regulatory kinase that adds the inhibitory phosphate groups to convert primed glycogen synthase from the active form to the inactive form.
In hepatic tissue, GSK3 / GST3 maintains constitutive basal activity unless actively inhibited.
Insulin signaling exerts dual control over this mechanism: it activates PP1 to remove phosphates from glycogen synthase while simultaneously transmitting inhibitory signals to shut down GSK3 / GST3, preventing re-phosphorylation and locking glycogen synthase in the active state.
Integrated Hormonal Signaling Cascades
Core metabolic junction:
Reciprocal regulation controls the bidirectional metabolic axis between glucose 1-phosphate and polymeric glycogen:
: Driven by active glycogen synthase during periods of glucose abundance.
: Driven by active glycogen phosphorylase during energy demand (glycogenolysis).
Insulin-mediated signaling coordination:
Insulin stimulates Protein Phosphatase 1 (PP1).
PP1 removes phosphate groups from glycogen phosphorylase, inactivating it and shutting down glycogen breakdown.
PP1 removes phosphate groups from glycogen synthase, activating it and stimulating glycogen synthesis.
Concurrently, insulin signaling stimulates glycolysis to promote cellular glucose utilization.
Glucagon and epinephrine signaling cascades:
Glucagon (in liver) and epinephrine (in liver and muscle) bind to G-protein coupled receptors.
Activated receptors stimulate adenylyl cyclase to synthesize cyclic AMP (.
Elevated activates Protein Kinase A (PKA).
PKA phosphorylates and activates phosphorylase kinase.
Phosphorylase kinase phosphorylates glycogen phosphorylase, converting it to the active form to initiate glycogenolysis.
Downstream kinases concomitantly phosphorylate glycogen synthase, converting it into the inactive form.
In hepatic tissue, glucagon signaling simultaneously downregulates glycolysis and stimulates gluconeogenesis to favor glucose production and export.
Tissue-Specific Fates of Glycogen Breakdown: Muscle vs. Liver
Receptor profiles across tissue types:
Skeletal muscle cells: Express epinephrine receptors but lack glucagon receptors; muscle tissue does not respond to starvation signaling via glucagon.
Liver cells (hepatocytes): Express both glucagon receptors and epinephrine receptors, responding to systemic nutritional depletion as well as acute stress.
Metabolic fate of glycogen in skeletal muscle:
Epinephrine stimulation activates glycogen phosphorylase, cleaving glycogen into glucose 1-phosphate.
Phosphoglucomutase converts glucose 1-phosphate into glucose 6-phosphate.
Skeletal muscle retains glucose 6-phosphate internally, channeling it directly into glycolysis to synthesize for actomyosin contractile work.
Muscle tissue does not express glucose 6-phosphatase; it retains its carbohydrate stores strictly for internal metabolic demands.
Metabolic fate of glycogen in the liver:
Hormonal stimulation by either glucagon or epinephrine activates glycogenolysis, generating glucose 1-phosphate, which is converted to glucose 6-phosphate.
The primary role of hepatic glycogen breakdown is altruistic: maintaining systemic blood glucose concentration to supply peripheral tissues, such as the brain and contracting muscle.
Hepatocytes catalyze the terminal reaction of gluconeogenesis using the enzyme glucose 6-phosphatase, which dephosphorylates glucose 6-phosphate to yield free glucose.
Free glucose exits the hepatocyte into the systemic circulation via facilitated transport.
While glycogen is degraded and free glucose is exported, intrahepatic glycolysis remains downregulated.
Questions and Discussion
Closing Session Inquiry:
Open prompt: "Alright. So any questions about this?"
Context: Concluding query marking the transition from the discussion of reciprocal hormonal regulation, glycogen storage enzymes, and tissue-specific metabolic fates.